ArdorComm Media Group

Tuesday, September 22, 2026 12:32 PM

medical science

ICMR-NIN Study Finds Vitamin D3 More Effective Than D2 in Supporting Muscle and Heart Health

Vitamin D3 may be more effective than Vitamin D2 in maintaining and restoring skeletal muscle and cardiac function, according to a study conducted by researchers at the ICMR-National Institute of Nutrition (ICMR-NIN), Hyderabad. The study, titled “Dietary Vitamin D2 Is Less Potent Than Vitamin D3 at Maintaining or Restoring Structure and Metabolism of Skeletal Muscle and Heart in Male Rats,” was published in Molecular Nutrition & Food Research. Researchers examined the comparative effects of Vitamin D2 and D3 on skeletal muscle and heart health in male rats during both the maintenance phase and recovery from vitamin D deficiency. Vitamin D is primarily known for its role in calcium regulation and bone health, but it also contributes to the functioning of tissues such as skeletal muscle and the heart. While both D2 and D3 are commonly used in supplements and food fortification, researchers noted that their effects on non-bone tissues have not been studied as extensively. For the study, weaning male Sprague-Dawley rats were divided into groups receiving diets containing Vitamin D2, Vitamin D3, a combination of both, or a vitamin D-deficient diet. Researchers subsequently assessed body composition, muscle strength, muscle structure and metabolism, along with indicators linked to cardiac function. The findings showed that Vitamin D3 resulted in greater improvements in muscle mass, muscle fibre size and grip strength compared with Vitamin D2. It also demonstrated stronger effects on biological markers associated with muscle development and energy metabolism. A similar trend was observed in the heart. Vitamin D3 produced greater changes in markers linked to cardiac contractility and metabolism. The differences between the two forms were particularly noticeable when the animals were recovering from Vitamin D deficiency. Dr Ayesha Ismail, Scientist F at ICMR-NIN and corresponding author of the study, said both forms improved calcium-related parameters, but Vitamin D2 was less effective across several indicators associated with muscle and heart structure and energy metabolism. ICMR-NIN Director Dr Bharati Kulkarni said the findings suggest that Vitamin D3 could have greater potential than Vitamin D2 in maintaining and restoring skeletal muscle and cardiac functions. However, the researchers cautioned against directly applying the findings to humans. They said additional research involving human populations is needed to determine whether the observed differences between Vitamin D2 and D3 have similar implications for skeletal and other body functions. The study adds to existing evidence suggesting that the two forms of Vitamin D may not have identical effects beyond their established role in calcium regulation and bone health. Researchers said further studies will be important in assessing the potential implications for vitamin supplementation and food-fortification programmes. Source: ANI

ICMR-NIN Study Finds Vitamin D3 More Effective Than D2 in Supporting Muscle and Heart Health Read More »

Targeting TB Bacteria’s Fatty Outer Coat May Boost Drug Effectiveness: IIT Bombay–Monash Study

Researchers from IIT Bombay and Monash University have discovered that the fatty outer coat of Mycobacterium tuberculosis—the bacteria that causes TB—plays a crucial role in helping it evade antibiotics. By altering this lipid-rich membrane, TB bacteria can survive drug treatment, especially when they enter a dormant state. Despite over a century of research, tuberculosis remains a major global threat. In 2023, 10.8 million people fell ill and 1.25 million died from the disease, with India recording more than 2.6 million cases in 2024. One of the biggest hurdles in treatment is the bacteria’s ability to slip into dormancy shortly after infection. In this phase, the bacteria remain alive but inactive, causing no symptoms and unable to spread. However, if a person’s immunity drops—due to HIV, illness or immunosuppressive medication—the bacteria can reactivate. Since standard TB drugs mainly target bacteria that are actively growing, dormant cells are far less affected and often survive long treatment cycles. The new study led by Prof Shobhna Kapoor of IIT Bombay and Prof Marie-Isabel Aguilar of Monash University examined how TB bacteria survive this drug assault. The researchers found that the dormant bacteria’s outer membrane undergoes changes that make it harder for antibiotics to penetrate. Drug concentrations needed to inhibit these dormant cells were up to ten times higher than those needed for active ones. Advanced mass spectrometry allowed the team to map more than 270 lipid molecules in the bacterial membranes, revealing significant differences between active and dormant bacterial states. According to the researchers, weakening this lipid barrier could make existing drugs far more effective. Instead of relying solely on new antibiotics, combining current treatments with molecules that disrupt the outer membrane could help kill persistent bacteria without promoting genetic resistance. Prof Kapoor noted that such an approach could shorten therapy durations and restore drug sensitivity, giving TB bacteria little room to adapt permanently. Source: PTI

Targeting TB Bacteria’s Fatty Outer Coat May Boost Drug Effectiveness: IIT Bombay–Monash Study Read More »